Sökning: onr:"swepub:oai:DiVA.org:uu-134979" >
A signal for an abu...
-
Schwan, Sofie
(författare)
A signal for an abuse liability for pregabalin-results from the Swedish spontaneous adverse drug reaction reporting system
- Artikel/kapitelEngelska2010
Förlag, utgivningsår, omfång ...
-
2010-06-19
-
Springer Science and Business Media LLC,2010
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-134979
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-134979URI
-
https://doi.org/10.1007/s00228-010-0853-yDOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:121119618URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Pregabalin is a gamma-aminobutyric acid (GABA) analogue approved for the treatment of epilepsy, neuropathic pain and generalised anxiety disorder. As a GABA analogue, there has been some concern about an abuse liability. We aimed to investigate the possible abuse liability of pregabalin. By applying a Bayesian data-mining algorithm to reports of possible drug abuse or addiction in the Swedish national register of adverse drug reactions (SWEDIS), we calculated the information component (IC) for pregabalin and reports of abuse and addiction. Out of 198 reports indicative of abuse or addiction to any drug, 16 concerned pregabalin. The IC became significantly elevated in the fourth quarter of 2008, rising to 3.99 (95% confidence interval 3.21-4.59) at the end of 2009. Based on the signal from the present study, we conclude that pregabalin is likely to be associated with an abuse potential.
Ämnesord och genrebeteckningar
-
Pregabalin
-
Abuse
-
Addiction
-
Adverse drug reaction
-
Data-mining
-
MEDICINE
-
MEDICIN
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Sundström, AndersKarolinska Institutet
(författare)
-
Stjernberg, ElisabetUppsala universitet,Klinisk farmakologi
(författare)
-
Hallberg, EbbaUppsala universitet,Klinisk farmakologi
(författare)
-
Hallberg, PärUppsala universitet,Klinisk farmakologi(Swepub:uu)pahal677
(författare)
-
Karolinska InstitutetKlinisk farmakologi
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:European Journal of Clinical Pharmacology: Springer Science and Business Media LLC66:9, s. 947-9530031-69701432-1041
Internetlänk
Hitta via bibliotek
Till lärosätets databas